-
Improvement effect of different weight loss on non-alcoholic fatty liver disease in obese children and adolescents
- CHENG Guodong, ZHU Lin, QIN Yuling
-
2025, 33(2):
149-154.
DOI: 10.11852/zgetbjzz2024-0664
-
Asbtract
(
)
PDF (667KB)
(
)
-
References |
Related Articles |
Metrics
Objective To investigate the effects of different levels of weight loss on body fat, blood lipids, blood glucose, liver function, and liver morphology in obese children and adolescents with non-alcoholic fatty liver disease (NAFLD). Methods From July to September 2023, seventy obese children and adolescents with NAFLD were recruited from a closed weight loss camp and underwent a 4-week weight loss intervention. Various test indicators were collected from the participants one day before the intervention and four weeks after the intervention. Based on the percentage of weight loss (WL) and clinical guideline recommendations, the participants were divided into a low WL group (WL<5%), a moderate WL group (5%≤WL<7%), and a high WL group (WL≥7%). The paired-sample t-test was used to compare changes in indicators within groups, one-way ANOVA was used to compare differences in improvement effects between groups, and a generalized regression model was used to analyze the relationship between weight change and blood glucose, blood lipids, and liver enzymes. Results A total of 61 participants were included in the analysis. After the 4-week weight loss intervention, there were significant decreases in body fat (BF) (t=6.471, 9.991, 13.351) and fat percentage (FP) (t=6.240, 5.549, 7.616) in the three NAFLD groups (P<0.05). Low-density lipoprotein cholesterol (LDL-C) significantly improved in all three groups (t=3.403, 9.218, 7.844, P<0.05), and the decrease in serum total cholesterol (TC) was statistically significant only in the 5%≤WL<7% and WL≥7% groups (t=7.114, 6.735,P<0.05). Serum gamma-glutamyltransferase (GGT) (t=5.082, 4.275, 5.003) and serum cholinesterase (ChE) (t=6.708, 9.254, 10.941) were significantly reduced (P<0.05). Alkaline phosphatase (ALP) (t=3.842, 4.584) and lactate dehydrogenase (LDH) (t=3.065, 3.869, P<0.05) decreased significantly in the 5%≤WL<7% and WL≥7% groups, and aspartate aminotransferase (AST) decreased significantly in the WL≥7% group (t=2.115, P<0.05). Using the percentage of weight change as the independent variable and a generalized linear regression model for trend testing, it was found that serum TC, ALP, LDL-C, TG, and ChE exhibited a linear trend across weight change groups (P<0.05). Conclusion Weight loss intervention can significantly improve glucose and lipid metabolism and liver function in obese children and adolescents with NAFLD, and with increasing amounts of weight loss, there is a trend of increased improvement in NAFLD liver enzymes.